Your browser doesn't support javascript.
loading
9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial.
Gerhard-Hartmann, Elena; Goergen, Helen; Bröckelmann, Paul J; Mottok, Anja; Steinmüller, Tabea; Grund, Johanna; Zamò, Alberto; Ben-Neriah, Susana; Sasse, Stephanie; Borchmann, Sven; Fuchs, Michael; Borchmann, Peter; Reinke, Sarah; Engert, Andreas; Veldman, Johanna; Diepstra, Arjan; Klapper, Wolfram; Rosenwald, Andreas.
Afiliación
  • Gerhard-Hartmann E; Institute of Pathology, University of Würzburg, Würzburg, Germany.
  • Goergen H; Comprehensive Cancer Center Mainfranken, Würzburg, Germany.
  • Bröckelmann PJ; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD) and German Hodgkin Study Group (GHSG), University of Cologne, Cologne, Germany.
  • Mottok A; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD) and German Hodgkin Study Group (GHSG), University of Cologne, Cologne, Germany.
  • Steinmüller T; Faculty of Medicine and University Hospital of Cologne, Mildred Scheel School of Oncology Aachen Bonn Cologne Düsseldorf (MSSO ABCD), Cologne, Germany.
  • Grund J; Department of Pathology, University Hospital Gießen and Marburg GmbH, Gießen, Germany.
  • Zamò A; Institute of Pathology, University of Würzburg, Würzburg, Germany.
  • Ben-Neriah S; Comprehensive Cancer Center Mainfranken, Würzburg, Germany.
  • Sasse S; Hematopathology Section and Lymph Node Registry, Department of Pathology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Borchmann S; Institute of Pathology, University of Würzburg, Würzburg, Germany.
  • Fuchs M; Comprehensive Cancer Center Mainfranken, Würzburg, Germany.
  • Borchmann P; Department for Lymphoid Cancer Research and Center for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
  • Reinke S; Department IV of Internal Medicine, University Hospital of Aachen, University of Aachen, Aachen, Germany.
  • Engert A; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD) and German Hodgkin Study Group (GHSG), University of Cologne, Cologne, Germany.
  • Veldman J; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD) and German Hodgkin Study Group (GHSG), University of Cologne, Cologne, Germany.
  • Diepstra A; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD) and German Hodgkin Study Group (GHSG), University of Cologne, Cologne, Germany.
  • Klapper W; Hematopathology Section and Lymph Node Registry, Department of Pathology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Rosenwald A; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD) and German Hodgkin Study Group (GHSG), University of Cologne, Cologne, Germany.
Br J Haematol ; 196(1): 116-126, 2022 01.
Article en En | MEDLINE | ID: mdl-34520052
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Translocación Genética / Cromosomas Humanos Par 9 / Enfermedad de Hodgkin / Antígeno B7-H1 Tipo de estudio: Prognostic_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Br J Haematol Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Translocación Genética / Cromosomas Humanos Par 9 / Enfermedad de Hodgkin / Antígeno B7-H1 Tipo de estudio: Prognostic_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Br J Haematol Año: 2022 Tipo del documento: Article País de afiliación: Alemania